Limaxetin

Recall | Medicines | 12/06/2018

The marketing authorization holder has informed its supplied customers in a letter dated 11.06.2018 that visible particles were found in part of a production batch during quality control. For this reason, the above batch is being recalled as a precautionary measure.

Name of the medicinal product LiMAxetin 4 mg/ml Injektionslösung
Marketing authorisation number(s) 138125
Marketing authorisation holder Humedics GmbH
Batch number(s) 2018AT01/A
Classification of the recall1
BASG reference number INS-640.001-2558
Email

Further inquiry note